These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17646110)

  • 1. Codon engineering for improved antibody expression in mammalian cells.
    Carton JM; Sauerwald T; Hawley-Nelson P; Morse B; Peffer N; Beck H; Lu J; Cotty A; Amegadzie B; Sweet R
    Protein Expr Purif; 2007 Oct; 55(2):279-86. PubMed ID: 17646110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons.
    Kofman A; Graf M; Bojak A; Deml L; Bieler K; Kharazova A; Wolf H; Wagner R
    Tsitologiia; 2003; 45(1):86-93. PubMed ID: 12683241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing scaleup yield for protein production: Computationally Optimized DNA Assembly (CODA) and Translation Engineering.
    Hatfield GW; Roth DA
    Biotechnol Annu Rev; 2007; 13():27-42. PubMed ID: 17875472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and repair of positive binding antibodies containing randomly generated amber codons from synthetic phage display libraries.
    Marcus WD; Lindsay SM; Sierks MR
    Biotechnol Prog; 2006; 22(3):919-22. PubMed ID: 16739981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codon optimization can improve expression of human genes in Escherichia coli: A multi-gene study.
    Burgess-Brown NA; Sharma S; Sobott F; Loenarz C; Oppermann U; Gileadi O
    Protein Expr Purif; 2008 May; 59(1):94-102. PubMed ID: 18289875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput, combinatorial engineering of initial codons for tunable expression of recombinant proteins.
    Ahn JH; Keum JW; Kim DM
    J Proteome Res; 2008 May; 7(5):2107-13. PubMed ID: 18386915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant DNA technology for engineering mammalian cells to produce proteins.
    Kaufman RJ
    Bioprocess Technol; 1990; 10():15-69. PubMed ID: 1367057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature?
    Dinnis DM; James DC
    Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of effect of gene copy number and mRNA level on the amount of mAb secretion from mammalian cells.
    Reisinger H; Steinfellner W; Stern B; Katinger H; Kunert R
    Appl Microbiol Biotechnol; 2008 Dec; 81(4):701-10. PubMed ID: 18810429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation of stable, high MAb expressing CHO cell lines based on the artificial chromosome expression (ACE) technology.
    Kennard ML; Goosney DL; Monteith D; Zhang L; Moffat M; Fischer D; Mott J
    Biotechnol Bioeng; 2009 Oct; 104(3):540-53. PubMed ID: 19557833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Cryptosporidium parvum infection of a mammalian cell culture by recombinant scFv antibodies.
    Pokorny NJ; Boulter-Bitzer JI; Hall JC; Trevors JT; Lee H
    Antonie Van Leeuwenhoek; 2008 Oct; 94(3):353-64. PubMed ID: 18581250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synergistic effect of suppressive CGG codon in +2 position and downstream CAT repeats for efficient heterologous protein expression in Escherichia coli.
    Pai VR; Murugan V
    Biochem Biophys Res Commun; 2008 Jul; 371(3):380-4. PubMed ID: 18440305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of hapten-specific monoclonal avian IgY by conversion of antibody fragments obtained from combinatorial libraries.
    Deckers S; Braren I; Greunke K; Meyer N; Rühl D; Bredehorst R; Spillner E
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):79-87. PubMed ID: 18627355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies.
    Villani ME; Morgun B; Brunetti P; Marusic C; Lombardi R; Pisoni I; Bacci C; Desiderio A; Benvenuto E; Donini M
    Plant Biotechnol J; 2009 Jan; 7(1):59-72. PubMed ID: 18793269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient bacterial production of functional antibody fragments using a phagemid vector.
    Kuba H; Furukawa A; Okajima T; Furukawa K
    Protein Expr Purif; 2008 Apr; 58(2):292-300. PubMed ID: 18077183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA secondary structure at start AUG codon is a key limiting factor for human protein expression in Escherichia coli.
    Zhang W; Xiao W; Wei H; Zhang J; Tian Z
    Biochem Biophys Res Commun; 2006 Oct; 349(1):69-78. PubMed ID: 16930549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of target-specific recombinant human polyclonal antibodies in mammalian cells.
    Wiberg FC; Rasmussen SK; Frandsen TP; Rasmussen LK; Tengbjerg K; Coljee VW; Sharon J; Yang CY; Bregenholt S; Nielsen LS; Haurum JS; Tolstrup AB
    Biotechnol Bioeng; 2006 Jun; 94(2):396-405. PubMed ID: 16596663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression studies of the HCV-1a core+1 open reading frame in mammalian cells.
    Vassilaki N; Boleti H; Mavromara P
    Virus Res; 2008 May; 133(2):123-35. PubMed ID: 18243391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized gene synthesis and high expression of human interleukin-18.
    Li A; Kato Z; Ohnishi H; Hashimoto K; Matsukuma E; Omoya K; Yamamoto Y; Kondo N
    Protein Expr Purif; 2003 Nov; 32(1):110-8. PubMed ID: 14680947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.